Abstract
Non-alcoholic fatty liver disease (NAFLD) is a worldwide epidemic and may progress, in the long run, to steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma (HCC). There is an immediate need to better understand its pathogenesis, as well as to develop an effective therapy to prevent its evolution to the most severe forms. Based on these observations, we aim to evaluate…